161 related articles for article (PubMed ID: 21599000)
1. Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.
Chen YW; Chen YL; Tseng CH; Liang CC; Yang CN; Yao YC; Lu PJ; Tzeng CC
J Med Chem; 2011 Jul; 54(13):4446-61. PubMed ID: 21599000
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives.
Chen YL; Chen IL; Wang TC; Han CH; Tzeng CC
Eur J Med Chem; 2005 Sep; 40(9):928-34. PubMed ID: 15913847
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. Part 2.
Tseng CH; Tzeng CC; Yang CL; Lu PJ; Chen HL; Li HY; Chuang YC; Yang CN; Chen YL
J Med Chem; 2010 Aug; 53(16):6164-79. PubMed ID: 20662543
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative evaluation of 4-anilino-n-methoxyfuro[2,3-b]quinoline derivatives (n=6, 7). Part 5.
Chen YL; Lin HC; Yang CN; Lu PJ; Tzeng CC
Chem Biodivers; 2008 Feb; 5(2):267-78. PubMed ID: 18293440
[TBL] [Abstract][Full Text] [Related]
5. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
Tsou HR; Overbeek-Klumpers EG; Hallett WA; Reich MF; Floyd MB; Johnson BD; Michalak RS; Nilakantan R; Discafani C; Golas J; Rabindran SK; Shen R; Shi X; Wang YF; Upeslacis J; Wissner A
J Med Chem; 2005 Feb; 48(4):1107-31. PubMed ID: 15715478
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic evaluation of certain 4-anilino-2-phenylquinoline derivatives.
Zhao YL; Chen YL; Chang FS; Tzeng CC
Eur J Med Chem; 2005 Aug; 40(8):792-7. PubMed ID: 16122581
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of polyenylpyrrole derivatives as anticancer agents acting through caspases-dependent apoptosis.
Fang Z; Liao PC; Yang YL; Yang FL; Chen YL; Lam Y; Hua KF; Wu SH
J Med Chem; 2010 Nov; 53(22):7967-78. PubMed ID: 20964408
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a novel Her-1/Her-2 dual tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-resistant non-small cell lung cancer.
Cha MY; Lee KO; Kim JW; Lee CG; Song JY; Kim YH; Lee GS; Park SB; Kim MS
J Med Chem; 2009 Nov; 52(21):6880-8. PubMed ID: 19888761
[TBL] [Abstract][Full Text] [Related]
9. Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer.
Han C; Huang Z; Zheng C; Wan L; Zhang L; Peng S; Ding K; Ji H; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4738-48. PubMed ID: 23668441
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers.
Lo WF; Chou YW; Tseng CH; Shiu YH; Chen YW; Yang SC; Chen YL; Lin MF; Tzeng CC
Anticancer Agents Med Chem; 2015; 15(4):493-500. PubMed ID: 25612680
[TBL] [Abstract][Full Text] [Related]
11. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic evaluation of certain 4-(phenylamino)furo[2,3-b]quinoline and 2-(furan-2-yl)-4-(phenylamino)quinoline derivatives.
Zhao YL; Chen YL; Tzeng CC; Chen IL; Wang TC; Han CH
Chem Biodivers; 2005 Feb; 2(2):205-14. PubMed ID: 17191973
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis and biological evaluation of 3-quinolinecarbonitrile-7-amide derivatives].
Liu B; You QD; Li ZY
Yao Xue Xue Bao; 2009 Aug; 44(8):879-84. PubMed ID: 20055156
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3481-4. PubMed ID: 19467598
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as potential antitumor agents.
Vázquez MT; Romero M; Pujol MD
Bioorg Med Chem; 2004 Mar; 12(5):949-56. PubMed ID: 14980607
[TBL] [Abstract][Full Text] [Related]
16. In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative.
Hollingshead M; Alley M; Burger AM; Borgel S; Pacula-Cox C; Fiebig HH; Sausville EA
Cancer Chemother Pharmacol; 2005 Aug; 56(2):115-25. PubMed ID: 15791458
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives.
Chang FS; Chen W; Wang C; Tzeng CC; Chen YL
Bioorg Med Chem; 2010 Jan; 18(1):124-33. PubMed ID: 19944612
[TBL] [Abstract][Full Text] [Related]
19. 4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.
Zhang N; Wu B; Boschelli DH; Golas JM; Boschelli F
Bioorg Med Chem Lett; 2009 Sep; 19(17):5071-4. PubMed ID: 19632113
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative evaluation of 6-arylindeno[1,2-c]quinoline derivatives.
Tseng CH; Chen YL; Chung KY; Cheng CM; Wang CH; Tzeng CC
Bioorg Med Chem; 2009 Nov; 17(21):7465-76. PubMed ID: 19796956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
